Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, July 2003, p. 2082-2087, Vol. 47, No. 7
0066-4804/03/$08.00+0 DOI: 10.1128/AAC.47.7.2082-2087.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Department of Microbiology, Mahidol University, Bangkok 10700, Thailand,1 Department of Microbiology and Infectious Diseases, University of Calgary Health Sciences Centre, Calgary, Alberta, Canada T2N 4N122
Received 25 October 2002/ Returned for modification 24 January 2003/ Accepted 29 March 2003
Burkholderia pseudomallei, the causative agent of melioidosis, is inherently resistant to a variety of antibiotics including aminoglycosides, macrolides, polymyxins, and ß-lactam antibiotics. Despite resistance to many ß-lactams, ceftazidime and ß-lactamase inhibitor-ß-lactam combinations are commonly used for treatment of melioidosis. Here, we examine the enzyme kinetics of ß-lactamase isolated from mutants resistant to ceftazidime and clavulanic acid inhibition and describe specific mutations within conserved motifs of the ß-lactamase enzyme which account for these resistance patterns. Sequence analysis of regions flanking the B. pseudomallei penA gene revealed a putative regulator gene located downstream of penA. We have cloned and sequenced the penA gene from B. mallei and found it to be identical to penA from B. pseudomallei.
This article has been cited by other articles:
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |